Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Des patrons de Theratechnologies achètent

<< Previous

Bullboard Posts

Next >>

Post by bassinion Nov 02, 2023 9:40am

151 Views

Post# 35713182

Des patrons de Theratechnologies achètent

Le grand patron, Paul Lvesque, le chef de la direction financire, Philippe Dubuc, le chef de la direction commerciale mondiale, John Leasure, la prsidente du conseil d’administration, Dawn Svoronos, ainsi que les administrateurs Andrew Molson, Joseph Arena et Grald Lacoste ont achet ensemble un total de 275 500 actions diffrents prix sur le march.

<< Previous

Bullboard Posts

Next >>

Bombardier Defense expands in Australia